Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, noviembre 03
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Danaher Corp
DHR
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$227.97
-4.26
-1.83%
Últ. Act.: Nov 2, 5:40 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Danaher Financials
Danaher (DHR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year
Dan Loeb’s Third Point increased its Danaher stake to 540,000 shares in the second quarter, up from 525,000, with a $102.8 million valuation.
Lekha Gupta
Danaher Posts First Earnings Under New CEO; Emphasizes Need For Improved Execution, Innovation
Danaher shares fell despite upbeat Q3 results. TD Cowen raised its target, citing tariffs and a cautious 2027 outlook.
Priya Nigam
Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
Danaher beat Q3 earnings and revenue estimates, raised FY2026 profit guidance, and analysts lifted price targets despite shares falling 1.8%.
Avi Kapoor
Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves
Danaher topped Q3 earnings estimates at $2.11 per share on $6.55 billion revenue, raising its full-year 2026 adjusted EPS outlook on steady biopharma demand.
Vandana Singh
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International, Thermo Fisher
Benzinga Insights
PRO
Danaher Sees Q4 2026 Non-GAAP Core Revenue Excluding Respiratory Revenue Up 4%-5% YoY
Danaher (NYSE:DHR) expects fourth quarter of 2026 non-GAAP core revenue, excluding respiratory revenue, to increase 4.0% to 5.0% year-over-year.
Benzinga Newsdesk
